0000874015-12-000013.txt : 20120105 0000874015-12-000013.hdr.sgml : 20120105 20120105190423 ACCESSION NUMBER: 0000874015-12-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120104 FILED AS OF DATE: 20120105 DATE AS OF CHANGE: 20120105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KLEIN JOSEPH III CENTRAL INDEX KEY: 0001206369 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 12512737 MAIL ADDRESS: STREET 1: C/O GENAISSANCE PHARMACEUTICALS INC STREET 2: FIVE SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 4 1 edgar.xml PRIMARY DOCUMENT X0304 4 2012-01-04 0000874015 ISIS PHARMACEUTICALS INC ISIS 0001206369 KLEIN JOSEPH III C/O ISIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 1 0 0 0 Employee Stock Option (right to buy) 9.77 2012-01-04 2012-01-04 4 G 0 12500 0 D 2011-07-02 2017-07-01 Common Stock 12500 0 D Employee Stock Option (right to buy) 13.88 2012-01-04 2012-01-04 4 G 0 11250 0 D 2012-07-01 2018-06-30 Common Stock 11250 3750 D Employee Stock Option (right to buy) 16.32 2012-01-04 2012-01-04 4 G 0 7500 0 D 2013-07-01 2019-06-30 Common Stock 7500 7500 D Employee Stock Option (right to buy) 9.22 2012-01-04 2012-01-04 4 G 0 3750 0 D 2014-07-01 2020-06-30 Common Stock 3750 11250 D Employee Stock Option (right to buy) 9.77 2012-01-04 2012-01-04 4 G 0 4166 0 A 2011-07-02 2017-07-01 Common Stock 4166 4166 I By Trust Employee Stock Option (right to buy) 13.88 2012-01-04 2012-01-04 4 G 0 3750 0 A 2009-07-01 2018-06-30 Common Stock 3750 3750 I By Trust Employee Stock Option (right to buy) 16.32 2012-01-04 2012-01-04 4 G 0 2500 0 A 2011-07-01 2019-06-30 Common Stock 2500 2500 I By Trust Employee Stock Option (right to buy) 9.22 2012-01-04 2012-01-04 4 G 0 1250 0 A 2011-07-01 2020-06-30 Common Stock 1250 1250 I By Trust Employee Stock Option (right to buy) 9.77 2012-01-04 2012-01-04 4 G 0 4167 0 A 2011-07-02 2017-07-01 Common Stock 4167 4167 I By Trust Employee Stock Option (right to buy) 13.88 2012-01-04 2012-01-04 4 G 0 3750 0 A 2010-07-01 2018-06-30 Common Stock 3750 3750 I By Trust Employee Stock Option (right to buy) 16.32 2012-01-04 2012-01-04 4 G 0 2500 0 A 2011-07-01 2019-06-30 Common Stock 2500 2500 I By Trust Employee Stock Option (right to buy) 9.22 2012-01-04 2012-01-04 4 G 0 1250 0 A 2011-07-01 2020-06-30 Common Stock 1250 1250 I By Trust Employee Stock Option (right to buy) 9.77 2012-01-04 2012-01-04 4 G 0 4167 0 A 2011-07-02 2017-07-01 Common Stock 4167 4167 I By Trust Employee Stock Option (right to buy) 13.88 2012-01-04 2012-01-04 4 G 0 3750 0 A 2011-07-01 2018-06-30 Common Stock 3750 3750 I By Trust Employee Stock Option (right to buy) 16.32 2012-01-04 2012-01-04 4 G 0 2500 0 A 2011-07-01 2019-06-30 Common Stock 2500 2500 I By Trust Employee Stock Option (right to buy) 9.22 2012-01-04 2012-01-04 4 G 0 1250 0 A 2011-07-01 2020-06-30 Common Stock 1250 1250 I By Trust The reporting person transfrerred options to trusts for his three children who share the reporting person's household Grant of 7/1/08 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, with the first installment vesting on 7/1/09. The option shall be fully vested and exercisable on 7-1-12. The option was exercisable as to 11,250 shares on 1/4/12. Grant of 7/1/09 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, with the first installment vesting on 7/1/10. The option shall be fully vested and exercisable on 7-1-13. The option was exercisable as to 7,500 shares on 1/4/12. Grant of 7/1/10 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, with the first installment vesting on 7/1/11. The option shall be fully vested and exercisable on 7-1-14. The option was exercisable as to 3,750 shares on 1/4/12. /s/B. Lynne Parshall, Attorney-In-Fact 2012-01-05